Mary Taj

961 total citations
29 papers, 550 citations indexed

About

Mary Taj is a scholar working on Oncology, Pathology and Forensic Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Mary Taj has authored 29 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Pathology and Forensic Medicine and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Mary Taj's work include Lymphoma Diagnosis and Treatment (12 papers), Acute Lymphoblastic Leukemia research (10 papers) and Viral-associated cancers and disorders (9 papers). Mary Taj is often cited by papers focused on Lymphoma Diagnosis and Treatment (12 papers), Acute Lymphoblastic Leukemia research (10 papers) and Viral-associated cancers and disorders (9 papers). Mary Taj collaborates with scholars based in United Kingdom, Germany and Spain. Mary Taj's co-authors include Julia Chisholm, David B. Mumford, L Price, Maria Zambon, Nedim Hadžić, Eva A. Wegner, Robert Robinson, Boo Messahel, Michael A. Smith and Sally F. Barrington and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Infectious Diseases.

In The Last Decade

Mary Taj

28 papers receiving 542 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Taj United Kingdom 13 219 127 125 96 96 29 550
Salvatore Buffardi Italy 12 164 0.7× 109 0.9× 176 1.4× 77 0.8× 98 1.0× 43 487
Hyery Kim South Korea 16 152 0.7× 148 1.2× 69 0.6× 118 1.2× 63 0.7× 100 665
Nicola Piccirillo Italy 14 176 0.8× 109 0.9× 94 0.8× 53 0.6× 59 0.6× 67 715
Olga Militano United States 12 176 0.8× 134 1.1× 65 0.5× 78 0.8× 57 0.6× 42 446
Xiaochun Zhu United States 12 250 1.1× 158 1.2× 147 1.2× 64 0.7× 63 0.7× 35 969
L. Brugiéres France 12 265 1.2× 128 1.0× 80 0.6× 102 1.1× 76 0.8× 28 789
Abraham S. Kanate United States 17 376 1.7× 103 0.8× 197 1.6× 61 0.6× 118 1.2× 61 815
Aarthi Shenoy United States 13 189 0.9× 71 0.6× 84 0.7× 55 0.6× 109 1.1× 41 649
Yijin Gao China 13 133 0.6× 126 1.0× 40 0.3× 98 1.0× 34 0.4× 66 511
Peter Waldron United States 13 117 0.5× 49 0.4× 79 0.6× 63 0.7× 78 0.8× 30 641

Countries citing papers authored by Mary Taj

Since Specialization
Citations

This map shows the geographic impact of Mary Taj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Taj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Taj more than expected).

Fields of papers citing papers by Mary Taj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Taj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Taj. The network helps show where Mary Taj may publish in the future.

Co-authorship network of co-authors of Mary Taj

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Taj. A scholar is included among the top collaborators of Mary Taj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Taj. Mary Taj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bomken, Simon, Rebecca E. Ling, Arina Lazareva, et al.. (2024). Management of paediatric monomorphic post‐transplant lymphoproliferative disorders with low‐intensity treatment: A multicentre international experience. Pediatric Blood & Cancer. 71(8). e31053–e31053. 1 indexed citations
2.
Taj, Mary, Britta Maecker‐Kolhoff, Rebecca E. Ling, et al.. (2021). Primary post‐transplant lymphoproliferative disorder of the central nervous system: characteristics, management and outcome in 25 paediatric patients. British Journal of Haematology. 193(6). 1178–1184. 10 indexed citations
3.
Taj, Mary, Anthony V. Moorman, Arnaud Petit, et al.. (2021). Prognostic value of Oncogenetic mutations in pediatric T Acute Lymphoblastic Leukemia: a comparison of UKALL2003 and FRALLE2000T protocols. Leukemia. 36(1). 263–266. 4 indexed citations
4.
Crossland, Rachel E., Sarah Wilkinson, Amir Enshaei, et al.. (2021). Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma. Leukemia. 36(3). 781–789. 23 indexed citations
5.
6.
Carceller, Fernando, Steffen Hirsch, Komel Khabra, et al.. (2019). High-dose etoposide and cyclophosphamide in adults and children with primary refractory and multiply relapsed acute leukaemias: The Royal Marsden experience. Leukemia Research. 85. 106217–106217. 4 indexed citations
7.
Taj, Mary, et al.. (2016). Comparison of Presentation and Outcome in 100 Pediatric Hodgkin Lymphoma Patients Treated at Children Hospital, Lahore, Pakistan and Royal Marsden Hospital, UK.. PubMed. 26(11). 904–907. 6 indexed citations
8.
Lee, Young, James L. Bedford, Mary Taj, & Frank Saran. (2013). Use of volumetric-modulated arc therapy for treatment of Hodgkin lymphoma. Medical dosimetry. 38(4). 372–375. 3 indexed citations
9.
Anoop, Parameswaran, et al.. (2012). Outcome of childhood relapsed or refractory mature B-cell non-Hodgkin lymphoma and acute lymphoblastic leukemia. Leukemia & lymphoma. 53(10). 1882–1888. 32 indexed citations
10.
Cazzaniga, Giovanni, Frederik W. van Delft, Luca Lo Nigro, et al.. (2011). Developmental origins and impact of BCR-ABL1 fusion and IKZF1 deletions in monozygotic twins with Ph+ acute lymphoblastic leukemia. Blood. 118(20). 5559–5564. 67 indexed citations
11.
Lashkari, Harsha Prasada, Donna Lancaster, Ayad Atra, M. P. Champion, & Mary Taj. (2011). Symptomatic severe hypertriglyceridaemia with asparaginase therapy in acute lymphoblastic leukaemia (ALL) and lymphoblastic lymphoma: is rechallenging safe?. International Journal of Hematology. 94(6). 571–575. 9 indexed citations
12.
13.
Bate, Jessica, Chee‐Fu Yung, Katja Höschler, et al.. (2010). Immunogenicity of Pandemic (H1N1) 2009 Vaccine in Children with Cancer in the United Kingdom. Clinical Infectious Diseases. 51(12). e95–e105. 23 indexed citations
14.
Dommett, Rachel, Sloane Freeman, John C. Hartley, et al.. (2009). Successful introduction and audit of a step-down oral antibiotic strategy for low risk paediatric febrile neutropaenia in a UK, multicentre, shared care setting. European Journal of Cancer. 45(16). 2843–2849. 41 indexed citations
15.
Taj, Mary, Boo Messahel, Kathy Pritchard‐Jones, et al.. (2007). Efficacy and tolerability of high‐dose methotrexate in central nervous system positive or relapsed lymphoproliferative disease following liver transplant in children. British Journal of Haematology. 140(2). 191–196. 30 indexed citations
16.
Taj, Mary, et al.. (2006). Secondary parotid mucoepidermoid carcinoma after TBI and chemotherapy in childhood AML. Pediatric Blood & Cancer. 47(3). 345–346. 6 indexed citations
17.
Chisholm, Julia, et al.. (2005). Influenza immunisation in children with solid tumours. European Journal of Cancer. 41(15). 2280–2287. 35 indexed citations
18.
Wegner, Eva A., Sally F. Barrington, J E Kingston, et al.. (2004). The impact of PET scanning on management of paediatric oncology patients. European Journal of Nuclear Medicine and Molecular Imaging. 32(1). 23–30. 53 indexed citations
19.
Taj, Mary, Lars D. Engstrom, Zhi Zeng, et al.. (2001). Mxi1, a Myc antagonist, suppresses proliferation of DU145 human prostate cells. The Prostate. 47(3). 194–204. 43 indexed citations
20.
Taj, Mary, et al.. (1993). Effect of Nutritional Status on the Incidence of Infection in Childhood Cancer. Pediatric Hematology and Oncology. 10(3). 283–287. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Salvatore Buffardi Breakdown of academic impact, for papers by Hyery Kim Breakdown of academic impact, for papers by Nicola Piccirillo Breakdown of academic impact, for papers by Olga Militano Breakdown of academic impact, for papers by Xiaochun Zhu Breakdown of academic impact, for papers by L. Brugiéres Breakdown of academic impact, for papers by Abraham S. Kanate Breakdown of academic impact, for papers by Aarthi Shenoy Breakdown of academic impact, for papers by Yijin Gao Breakdown of academic impact, for papers by Peter Waldron
Rankless by CCL
2026